What's the outlook for ASX healthcare shares in Q2?

Here are some of the numbers looking ahead.

| More on:
A doctor appears shocked as he looks through binoculars on a blue background.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • ASX healthcare shares have been underwhelming this year
  • Projections for the industry are a little more optimistic, with some of the larger players looking to secure gains
  • We've crunched the numbers to see what's on the horizon for the industry

ASX healthcare shares have been a mixed bag in 2022. The industry was flourishing during the later part of the last calendar year but took a turn as early as November.

The downside continued along with the broader sell-off in equities. However, unlike most other industries, it has failed to reclaim a good portion of the losses.

The S&P/ASX 200 Health Care Index (ASX: XHJ) is down more than 10% this year to date and is sitting around the same over the past 12 months.

What are the projections?

Healthcare is seen as a 'defensive' industry that is largely insensitive to the business cycle. With this in mind, the current and forward-looking economic climate are of interest to those looking at ASX healthcare shares.

The industry trades on a price-to-earnings (P/E) ratio of 30.09 times at the time of writing, and has delivered a trailing dividend yield of 1.62%.

Some of the largest players, such as CSL Limited (ASX: CSL), Resmed Inc (ASX: RMD), and Sonic Healthcare Limited (ASX: SHL), reside within this portion of the market.

Each of these dominant names has numerous bullish price targets that point to strength in the industry across a diverse array of services.

CSL is rated a buy from 13 out of 16 brokers covering the share, with a $320 consensus price target (all data sourced from Refinitiv Eikon). The CSL share price closed on Friday at $280.43.

Meanwhile, Resmed is also tipped as a buy from nine out of 14 analysts, with a consensus valuation of $36.10. Resmed shares ended Friday's session trading for $34.14 apiece.

Sonic is rated a buy from six out of the 15 analysts covering it, with a $35.86 price target assigned. The Sonic share price is $30.55 as of Friday's close.

Noteworthy is that each consensus price target is priced above the current market value of each share.

In addition, some of the largest ASX healthcare shares are posted in the table below, with their respective fundamentals. All figures are in millions of dollars (except earnings per share and percentage).

NameRevenue [$million]EBITDANet IncomeEPSFree Cash FlowROE (%)
S&P/ASX 200 Health Care Index (ASX: XHJ)1,992.3514.4281.6 $     0.8898.816.3
CSL Limited (ASX: CSL)15,304.95534.73267.2 $     6.97740.219.6
Resmed Inc (ASX: RMD)5,185.01683.51129.5 $     7.68779.125.0
Sonic Healthcare Limited (ASX: SHL)9,340.22835.81460.6 $     3.021356.921.4
Ramsay Health Care Limited (ASX: RHC)13,210.21334.1274.0 $     1.16229.36.9
Cochlear Limited (ASX: COH)1,648.3471.2289.1 $     4.4095.117.1
Fisher & Paykel Healthcare Corporation Ltd (ASX: FPH)15,58.9557.7349.4 $     0.6072.523.6
Pro Medicus Limited (ASX: PME)94.169.344.4 $     0.4223.948.5
Ansell Limited (ASX: ANN)2,828.7470.9230.0 $     1.79102.610.3
Healius Ltd (ASX: HLS)2,336.2766.9307.9 $     0.52380.915.6
Telix Pharmaceuticals Ltd (ASX: TLS)7.6-71.8-80.5 $   (0.29)-76.7-198.4
Imugene Limited (ASX: IMU)0.0-35.3-37.9 $   (0.01)-35.7-37.2
Nanosonics Ltd (ASX: NAN)120.37.63.7 $     0.012.52.7

With that, we can observe some names from the above list with projected earnings over the next two years in the table below as well.

 EPS   
NamePrevThis yearFY24FY25
S&P/ASX 200 Health Care (GIC) $   1.32 $   0.86 $   1.18 $   1.56
Resmed Inc $   4.32 $   7.68 $   8.47 $   9.46
CSL Ltd $   6.94 $   6.97 $   8.56 $ 10.40
Cochlear Ltd $   4.97 $   4.40 $   5.31 $   6.65
Sonic Healthcare Ltd $   2.73 $   3.02 $   1.72 $   1.56
Ansell Ltd $   2.53 $   1.79 $   2.23 $   2.09
Ramsay Health Care Ltd $   1.80 $   1.13 $   2.98 $   3.13
Fisher & Paykel Healthcare Corporation Ltd $   0.83 $   0.60 $   0.64 $   0.74
Healius Ltd $   0.11 $   0.50 $   0.21 $   0.22
Pro Medicus Ltd $   0.29 $   0.42 $   0.54 $   0.65
Nanosonics Ltd $   0.03 $   0.01 $   0.09 — 
Imugene Ltd $ (0.00) $ (0.01) $ (0.01) $ (0.01)
Telix Pharmaceuticals Ltd $ (0.17) $ (0.29) $ (0.30) $ (0.03)

Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL Ltd. and ResMed Inc. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended ResMed. The Motley Fool Australia has positions in and has recommended ResMed Inc. The Motley Fool Australia has recommended Sonic Healthcare Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

Should I buy the dip on CSL shares?

A leading fund manager gives his verdict on the growth prospects for CSL shares.

Read more »

A woman relaxes on a yellow couch with a book and cuppa, and looks pensively away as she contemplates the joy of earning passive income.
Healthcare Shares

NIB shares have soared 24% this year. Does Macquarie expect this to continue?

Will this private health insurer continue to deliver big returns? Let's find out.

Read more »

Woman presenting financial report on large screen in conference room.
Healthcare Shares

Up nearly 30% in a year, should I buy Fisher & Paykel shares before its earnings result?

Will the ASX 200 healthcare stock continue to outperform?

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

CSL shares among most expensive on ASX. Is now a good time to buy?

Analysts predict CSL share price growth will keep on coming.

Read more »

A man looking at his laptop and thinking.
Healthcare Shares

Should you buy the dip in the ResMed share price?

Let's see what one leading broker is saying following yesterday's pullback.

Read more »

A woman puts up her hands and looks confused while sitting at her computer.
Healthcare Shares

Down 5%: What's going on with the ResMed share price?

Let's see what has spooked investors today and caused them to push the sell button.

Read more »

Beautiful young woman drinking fresh orange juice in kitchen.
Healthcare Shares

Guess which ASX 300 stock is jumping 11% on big news

This stock is having a day to remember on Thursday. But why?

Read more »

A group of medical researchers stands side by side with each other wearing white coats in their research laboratory with scientific equipment in the background.
Healthcare Shares

Trump executive order to hit these 3 ASX pharmaceutical stocks

Donald Trump’s new executive order caused these 3 ASX pharmaceutical stocks to crash on Monday.

Read more »